A61K 31 - Medicinal preparations containing organic active ingredients

Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
12/1992
12/06/1992	CA2070505A1 Pharmaceutical compositions for the treatment of respiratory tract diseases
12/06/1992	CA2070494A1 Combination preparations for treatment of parkinson's disease
12/06/1992	CA2070468A1 Fatty acid treatment
12/06/1992	CA2070055A1 Excitatory amino acid receptor antagonists and methods for the use thereof
12/06/1992	CA2065078A1 Angiotensin ii antagonists incorporating a substituted indole or dihydroindole
12/05/1992	CA2070305A1 1-methylcarbapenem derivatives, their preparation and their use as antibiotics
12/05/1992	CA2070149A1 Hmg-coa reductase inhibitors in the prevention of restenosis following coronary angloplasty
12/05/1992	CA2043864A1 Direct compression cyclophosphamide tablet
12/04/1992	CA2070242A1 Fermentation analogs of virginiamycin m1
12/03/1992	DE4216644A1 Liposomen Liposomes
12/03/1992	DE4117854A1 Lipoxygenase inhibiting Celastroloid(s) - used for treating rheumatism, malaria, tumours or bacterial infection
12/03/1992	DE4117358A1 New tri:cyclic isoindole derivs.
12/03/1992	DE4117249A1 Linsidomin zur behandlung erektiler dysfunktionen Linsidomine for the treatment of erectile dysfunctions
12/02/1992	EP0516594A1 L-carnitine derivatives as therapeutical agents for treating myopathies and neuronal degeneration and for inhibiting proteolysis
12/02/1992	EP0516588A1 Substituted diaminophtalimides and analogues
12/02/1992	EP0516530A1 New 6-substituted steroids with a thioethyl group in the 10 position, a process for their preparation and intermediates therefor, their use as medicines and pharmaceutical compositions thereof
12/02/1992	EP0516520A1 1,4-Disubstituted piperidines, their preparation and therapeutical application
12/02/1992	EP0516410A2 Novel synthesis of 19-nor vitamin D compounds
12/02/1992	EP0516392A2 Naphthyridine derivatives as angiotensin II inhibitors
12/02/1992	EP0516350A2 2-Hydroxy-2-phenylethylamine derivatives as beta-3-adrenoceptor agonists
12/02/1992	EP0516349A2 2-Hydroxy-2-phenylethylamine derivatives as beta-3-adrenoceptor agonists
12/02/1992	EP0516345A1 Use of nizatidine for the manufacture of a medicament for the treatment of reflux esophagitis
12/02/1992	EP0516297A1 Pyridazinediones and their use in the treatment of neurological disorders
12/02/1992	EP0516278A1 Use of anti-mullerian hormone for reversal of female sexual phenotype in poultry
12/02/1992	EP0516257A1 Phenylbenzo[b]furans and -thiophenes, procedures for their preparation, and pharmaceutical compositions containing the same
12/02/1992	EP0516234A1 Phenoxyphenyl derivatives
12/02/1992	EP0516194A2 Pharmaceutical compositions containing cationic surfactants
12/02/1992	EP0516186A2 Nucleosides and nucleoside analogues, pharmaceutical composition and processes for the preparation of the compounds
12/02/1992	EP0516157A1 Preparation of 6-0-alkylelsamicin A derivatives
12/02/1992	EP0516156A1 Chemical modification of 2"-amino group in elsamicin A
12/02/1992	EP0516155A1 Chemical modification of elsamicin A at the 3' and/or 4'OH groups
12/02/1992	EP0516154A1 Preparation of 6-0-acylelsamicin a derivatives
12/02/1992	EP0516132A1 Anti-neuronotoxic activity and therapeutic applications of GM1 ganglioside methyl ester
12/02/1992	EP0516082A2 Gingerol and gingerdiol derivatives as hypocholesterolemic and antiatherosclerotic agents
12/02/1992	EP0516069A1 Leukotriene B4 antagonist
12/02/1992	EP0516034A1 Pharmaceutical compositions with immunosuppresive properties
12/02/1992	EP0516015A1 Substituted decarestrictines, methods for their preparation and use thereof
12/02/1992	EP0515940A1 New 2-amino-5-cyano-1,4-dihydropyridines, process for their preparation and use in pharmaceutical compositions
12/02/1992	EP0515927A2 Pradimicin antibiotics
12/02/1992	EP0515901A1 Antimycotic compositions containing phenylacetic acid derivatives
12/02/1992	EP0515866A1 Use of N-(2,6-dimethylphenyl)-2-(2-oxo-1-pyrrolidinyl) acetamide for the treatment of dementia
12/02/1992	EP0515758A1 Therapeutic use of 1,3-dimethylol-5,5-dimethyl hydantoin
12/02/1992	EP0515684A1 Inhibitor of denatured ldl formation
12/02/1992	EP0515668A1 OXO-TETRAHYDROPYRIDAZINYL-PYRAZOLO 4,3-b]-1,4-BENZOXAZINES
12/02/1992	EP0515550A1 Heparin neutralization with platelet factor 4
12/02/1992	EP0515548A1 Imidazole angiotensin ii antagonists incorporating a substituted benzyl element
12/02/1992	EP0515546A1 Triazole angiotensin ii antagonists incorporating a substituted benzyl element
12/02/1992	EP0515540A1 Derivative of beta-phenylisoserine, preparation and utilisation thereof.
12/02/1992	EP0515535A1 Angiotensin ii antagonists incorporating a substituted benzyl element
12/02/1992	EP0515523A1 Use of suramin to treat rheumatologic diseases
12/02/1992	EP0515517A1 Treatment of pruritis with esters and amides
12/02/1992	EP0515514A1 2-aralkoxy and 2-alkoxy adenosine derivatives as coronary vasodilators and antihypertensive agents
12/02/1992	EP0515510A1 Hydroquinone amino-acid esters, method of preparation, and pharmaceutical or cosmetic compositions containing them.
12/02/1992	EP0515509A1 Novel antiviral and antitumor terpene hydroquinones and methods of use
12/02/1992	EP0515460A1 Docosahexaenoic acid, methods for its production and compounds containing the same
12/02/1992	EP0515456A1 Branched fructo-oligosaccharides, a method for obtaining them and uses of products containing them.
12/02/1992	EP0515420A1 Nitric acid esters of cyclohexanol derivatives.
12/02/1992	EP0515386A1 Glycoalkaloids
12/02/1992	EP0357724B1 Stabilized heparin solution
12/02/1992	EP0302874B1 Indoloquinone compounds
12/02/1992	EP0294441B1 Composition to prevent seasickness
12/02/1992	CN1066657A Antibiotic compounds
12/02/1992	CN1066656A Amino acid azelidinyl substituted pyridone derivatives, their preparation and their application as medications
12/02/1992	CN1066654A Benzofuran derivatives
12/02/1992	CN1066653A Benzoheterocyclic compounds
12/02/1992	CN1066602A Compound melbine capsule and making process
12/02/1992	CN1066588A Fluoro carbon emulsion and its production process
12/02/1992	CN1019302B Polycyclic ether antibioties
12/02/1992	CN1019300B Process for manufacture of carboxylic acid amides
12/02/1992	CN1019299B 1-hydroxy-5-oxo-5h-pyrido(3,2-a) phenoxazine-3-carboxylic acid esters
12/02/1992	CN1019266B Preparation of artemisia apiacea ester for injection
12/01/1992	WO1992021677A1 bibNUCLIDINE DERIVATIVES
12/01/1992	WO1992021671A1 N-arylalkylderivatives of 2-aminomethyl-2,3-dihydro-1,4-benzodioxine and the process of preparation thereof
12/01/1992	WO1992021356A1 Hypertonic isochloremic formulation for circulatory shock
12/01/1992	WO1992021352A1 USE OF 1-(β-D-ARABINOFURANOSYL)-5-PROPYNYLURACIL FOR LOWERING SERUM CHOLESTEROL
12/01/1992	WO1992021341A1 Use of rapamycin prodrugs as immunosuppressant agents
12/01/1992	USRE34136 9 alpha, 11 beta-substituted and 11 beta-substituted estranes
12/01/1992	US5168103 Neuroprotectants, anticonvulsants
12/01/1992	US5168102 Endocrine manipulation to improve body composition of poultry
12/01/1992	US5168099 Optically active alkylenedioxybenzene derivatives and their use in therapy
12/01/1992	US5168098 Pyrrolo-pyridine derivatives and therapeutic compositions containing them
12/01/1992	US5168053 Ribonuclease and genetically-engineered external guide sequence of nucleotides as treatment for AIDS
12/01/1992	US5167965 Mixing with gum and water to form paste, extrusion, drying, pulverization
12/01/1992	US5167963 8,10-dideazatetrahydrofolic acid derivatives
12/01/1992	US5167959 Laxative compositions and a process for producing them
12/01/1992	US5167953 Compositions comprising tachysteral and the use thereof to provide vitamin D
12/01/1992	US5167949 Antiallergic
12/01/1992	US5167947 Enhancement of absorption of radioprotective drugs
12/01/1992	CA2103246A1 Hypertonic isochloremic formulation for circulatory shock
12/01/1992	CA2102116A1 Use of rapamycin prodrugs as immunosuppressant agents
12/01/1992	CA2102109A1 N-arylalkylderivatives of 2-aminomethyl-2,3-dihydro-1, 4-benzodioxine and the process of preparation thereof
12/01/1992	CA2088264A1 Nucleoside derivative
12/01/1992	CA2070124A1 Uses of a ganglioside derivative
12/01/1992	CA2070085A1 Ace inhibitor and calcium channel blocker for use in treating hypertension
12/01/1992	CA2069860A1 2-amino-5-cyano-1,4-dihydropyridines, processes for their preparation and their use in medicaments
12/01/1992	CA2069857A1 Substituted diaminophthalimides and analogues
12/01/1992	CA2069717A1 Chemical modification of 2"-amino group in elsamicin a
12/01/1992	CA2069716A1 Preparation of 6-0-alkylelsamicin a derivatives
12/01/1992	CA2069715A1 Chemical modification of elsamicin a at the 3' and/or 4'oh groups
12/01/1992	CA2069714A1 Preparation of 6-0-acylelsamicin a derivatives

1 ... 7229 7230 7231 7232 7233 7234 7235 7236 7237 7238 7239 7240 7241 7242 7243 7244 7245 7246 7247 7248 7249 ... 7860